Ainos (NASDAQ:AIMD) Announces Earnings Results

Ainos (NASDAQ:AIMD) issued its quarterly earnings results on Monday. The company reported ($0.85) earnings per share for the quarter, FiscalAI reports. Ainos had a negative return on equity of 128.04% and a negative net margin of 11,912.10%.The business had revenue of $0.01 million for the quarter.

Ainos Price Performance

Ainos stock opened at $1.39 on Wednesday. The company has a debt-to-equity ratio of 1.10, a current ratio of 2.96 and a quick ratio of 2.67. The business has a 50 day simple moving average of $1.63 and a 200-day simple moving average of $2.35. Ainos has a 12 month low of $1.26 and a 12 month high of $4.50. The stock has a market capitalization of $6.69 million, a PE ratio of -0.39 and a beta of 2.39.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ainos in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Insiders Place Their Bets

In related news, major shareholder Carbon Nano Technology Taiwan sold 46,000 shares of Ainos stock in a transaction on Wednesday, January 28th. The shares were sold at an average price of $2.17, for a total value of $99,820.00. Following the transaction, the insider directly owned 989,925 shares in the company, valued at $2,148,137.25. This trade represents a 4.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In the last 90 days, insiders have sold 47,281 shares of company stock valued at $102,152. Company insiders own 9.79% of the company’s stock.

Institutional Trading of Ainos

Hedge funds have recently made changes to their positions in the company. Mariner LLC acquired a new position in shares of Ainos during the fourth quarter worth about $37,000. Two Sigma Investments LP acquired a new stake in Ainos in the third quarter valued at about $80,000. DRW Securities LLC boosted its holdings in Ainos by 272.6% in the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock valued at $109,000 after purchasing an additional 48,439 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in Ainos by 13.1% in the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock valued at $109,000 after purchasing an additional 7,700 shares in the last quarter.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.